An investigation on behalf of investors in Soligenix, Inc. (NASDAQ: SNGX) shares over potential wrongdoing at Soligenix, Inc. was announced.
San Diego, CA -- (SBWIRE) -- 08/30/2018 -- An investigation was announced for investors in shares of Soligenix, Inc. (NASDAQ: SNGX) concerning potential breaches of fiduciary duties by certain officers and directors at Soligenix, Inc.
Investors who purchased shares of Soligenix, Inc. (NASDAQ: SNGX) have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Soligenix, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.
Princeton, NJ based Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. Soligenix, Inc. reported that its annual Total Revenue declined from over $10.44 million in 2016 to over $5.43 million in 2017 and that its Net Loss increased from over $3.24 million in 2016 to over $7.14 million in 2017.
Shares of Soligenix, Inc. (NASDAQ: SNGX) declined to as low as $0.91 per share in June 2018.
On August 29, 2018, NASDAQ: SNGX shares closed at $1.55 per shares.
Those who purchased shares of Soligenix, Inc. (NASDAQ: SNGX), have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels